Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Molecular Imaging and Radionuclide Therapy
|
February 4, 2026
Hepatic Vascular Shunts Mimicking Malignant Lesions on <sup>18</sup>F-FDG PET/CT Imaging: Interpretation Pitfall in the Background of Cirrhotic Liver
Sanchay Jain, Assim Saad Eddin, Parren McNeely, et al.
Cancers
|
August 28, 2025
PET/CT and Paraneoplastic Syndromes: A Comprehensive Review
Motaz Daraghma, Yashant Aswani, Sanchay Jain, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 5, 2026
A Phase 0 Imaging Trial of [<sup>203</sup>Pb]Pb-VMT-α-NET to Enable Dosimetry and Treatment Planning for Refractory or Relapsed Metastatic Neuroendocrine Tumors with [<sup>212</sup>Pb]Pb-VMT-α-NET
Stephen A Graves, David L Bushnell, Michael K Schultz, et al.
American Journal of Therapeutics
|
June 16, 2026
Outcomes With Peptide Receptor Radionuclide Therapy in Patients With Pheochromocytoma/Paraganglioma: A Center of Excellence Experience
Matthew T Gao, Rishi R Patel, Sanchay Jain, et al.
Journal of Neurointerventional Surgery
|
June 2, 2026
Yttrium-90 Radioembolization for Recurrent Meningioma: Rationale and Roadmap for Neurointerventional Translation
Aaron Daniel Brake, Kevin John, Sanchay Jain, et al.
Cancers
|
December 11, 2025
Enhancing PRRT Outcome Prediction in Neuroendocrine Tumors: Aggregated Multi-Lesion PET Radiomics Incorporating Inter-Tumor Heterogeneity
Maziar Sabouri, Ghasem Hajianfar, Omid Gharibi, et al.
EJNMMI Reports
|
November 29, 2024
Inter- and intra-tumoral heterogeneity on [<sup>68</sup>Ga]Ga-DOTA-TATE/[<sup>68</sup>Ga]Ga-DOTA-TOC PET/CT predicts response to [<sup>177</sup>Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients
Camila Gadens Zamboni, Ayca Dundar, Sanchay Jain, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Molecular Imaging and Radionuclide Therapy
|
February 4, 2026
Hepatic Vascular Shunts Mimicking Malignant Lesions on <sup>18</sup>F-FDG PET/CT Imaging: Interpretation Pitfall in the Background of Cirrhotic Liver
Sanchay Jain, Assim Saad Eddin, Parren McNeely, et al.
Cancers
|
August 28, 2025
PET/CT and Paraneoplastic Syndromes: A Comprehensive Review
Motaz Daraghma, Yashant Aswani, Sanchay Jain, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 5, 2026
A Phase 0 Imaging Trial of [<sup>203</sup>Pb]Pb-VMT-α-NET to Enable Dosimetry and Treatment Planning for Refractory or Relapsed Metastatic Neuroendocrine Tumors with [<sup>212</sup>Pb]Pb-VMT-α-NET
Stephen A Graves, David L Bushnell, Michael K Schultz, et al.
American Journal of Therapeutics
|
June 16, 2026
Outcomes With Peptide Receptor Radionuclide Therapy in Patients With Pheochromocytoma/Paraganglioma: A Center of Excellence Experience
Matthew T Gao, Rishi R Patel, Sanchay Jain, et al.
Journal of Neurointerventional Surgery
|
June 2, 2026
Yttrium-90 Radioembolization for Recurrent Meningioma: Rationale and Roadmap for Neurointerventional Translation
Aaron Daniel Brake, Kevin John, Sanchay Jain, et al.
Cancers
|
December 11, 2025
Enhancing PRRT Outcome Prediction in Neuroendocrine Tumors: Aggregated Multi-Lesion PET Radiomics Incorporating Inter-Tumor Heterogeneity
Maziar Sabouri, Ghasem Hajianfar, Omid Gharibi, et al.
EJNMMI Reports
|
November 29, 2024
Inter- and intra-tumoral heterogeneity on [<sup>68</sup>Ga]Ga-DOTA-TATE/[<sup>68</sup>Ga]Ga-DOTA-TOC PET/CT predicts response to [<sup>177</sup>Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients
Camila Gadens Zamboni, Ayca Dundar, Sanchay Jain, et al.
Page
of 2